Norbert F Zander

This inventor holds 27 USPTO granted patents and 17 published patent applications, plus 4 CIPO patents and 21 EPO patents, primarily in Blood Coagulation Diagnostics. Top assignees: Siemens Healthcare Diagnostics Products Gmbh, Fresenius Kabi Deutschland Gmbh, Dade Behring Marburg Gmbh. Active years: 1997-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Norbert F Zander. Retrieved from https://idiyas.com/inventor/norbert-f-zander

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 27 (Patent Applications = 17)

% Patents Active = 66.7

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 21 (Patent Applications = 41)

Average Co-Inventor Count = 2.4

ph-index = 7

Forward Citations = 103(Granted Patents)

Location History:

Meine, DE (2007 - 2014)
Marburg, DE (1997 - 2023)

Company Filing History:

14 out of 108

Siemens Healthcare Diagnostics Products Gmbh

patents

7 out of 229

Fresenius Kabi Deutschland Gmbh

patents

4 out of 149

Dade Behring Marburg Gmbh

patents

4. 1 out of 340

Behringwerke Aktiengesellschaft

patents

5. 1 out of 1

Behringwerke Diagnostics Gmbh

where one patent can have more than one assignee

Years Active: 1997-2026

Loading Chart...

Areas of Expertise:

Iron Chelator

Prothrombin Time

Thrombocytopenia

Coagulation Proteases

Platelet Function

Hydroxyalkyl Starch

D-Dimer

Recombinant Tissue Factor

Diagnostic Tests

Starch Derivatives

Coagulation Assays

Membrane Proteins

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12761221 - Method for determining lupus anticoagulant in a single coagulation reaction (2026-10-13),

2. 11774461 - Iron chelator-containing prothrombin time reagent (2023-10-03),

3. 11320439 - Binding assay for the diagnosis of a heparin-induced thrombocytopenia (2022-05-03),

4. 11262357 - Activation assay for the diagnosis of a heparin-induced thrombocytopenia (2022-03-01),

5. 10822636 - Method for determining fibrinogen and automatic analyzer (2020-11-03),

6. 9482673 - Method for simultaneously determining multiple coagulation proteases (2016-11-01),

7. 9205424 - Devices for determining the platelet function in a centrifugal analyzer (2015-12-08),

8. 8932826 - Method for simultaneously determining multiple coagulation proteases (2015-01-13),

9. 8906639 - Method of determining factor XIII with the aid of plasma-based reference material (2014-12-09),

10. 8840879 - Conjugates of hydroxyalkyl starch and a protein (2014-09-23),

11. 8741873 - Controls and kit for thrombocyte activity tests (2014-06-03),

12. 8685636 - Heparin-insensitive method for determining direct coagulation factor inhibitors (2014-04-01),

13. 8618266 - Hasylated polypeptides (2013-12-31),

14. 8475765 - Hydroxyalkyl starch derivatives (2013-07-02),

15. 8304205 - Blood coagulation assays (2012-11-06),

Title: Norbert F Zander - Pioneering Inventor from Marburg

Introduction: Norbert F Zander is a distinguished inventor hailing from Marburg, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Norbert F Zander holds several recent patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Norbert F Zander has worked with leading research institutions and tech companies, consistently pushing the boundaries of what is possible in the realm of technological advancements.

Collaborations: Throughout his career, Norbert F Zander has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Norbert F Zander's passion for innovation and his relentless drive to create solutions for the future make him a true pioneer in the world of inventions. His work continues to inspire and shape the landscape of technology worldwide.

Profile summary based on public USPTO records.